Literature DB >> 2931506

Myofibroblast activity of radial scars.

S Battersby, T J Anderson.   

Abstract

Radial scars from 38 cases, comprising 12 associated with cancer and 26 with benign lesions, have been examined by electron microscopy. One-third of the lesions, regarded as being at an early stage of development, showed abundant spindle cells, which displayed the ultrastructural characteristics of myofibroblasts. These included many profiles of endoplasmic reticulum, prominent myofilaments and a close association with collagen and elastic fibres. The remaining 'mature' radial scars showed relatively few myofibroblasts, sparsely distributed in the stroma. The stromal cells associated with the 'early' lesions were seen in close proximity to degenerating parenchymal structures, which frequently showed loss of basal lamina. Obliteration of the central parenchymal component appeared to be a prominent feature of radial scar formation. The ultrastructural appearances are consistent with a progressive development of the lesion, associated with sporadic myofibroblast activity.

Entities:  

Mesh:

Year:  1985        PMID: 2931506     DOI: 10.1002/path.1711470105

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  3 in total

Review 1.  Pathology and clinical relevance of radial scars: a review.

Authors:  M Kennedy; A V Masterson; M Kerin; F Flanagan
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

2.  The alpha-smooth muscle actin-positive cells in healing human myocardial scars.

Authors:  I E Willems; M G Havenith; J G De Mey; M J Daemen
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

3.  Next generation sequencing of the nidus of early (adenosquamous proliferation rich) radial sclerosing lesions of the breast reveals evidence for a neoplastic precursor lesion.

Authors:  Mark J Wilsher; Thomas W Owens; Richard Jn Allcock
Journal:  J Pathol Clin Res       Date:  2017-03-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.